155 related articles for article (PubMed ID: 31302030)
1. CUB domain-containing protein 1 (CDCP1) binds transforming growth factor beta family members and increase TGF-β1 signaling pathway.
Predes D; Cruz JVR; Abreu JG; Mendes FA
Exp Cell Res; 2019 Oct; 383(1):111499. PubMed ID: 31302030
[TBL] [Abstract][Full Text] [Related]
2. Cub domain-containing protein 1 negatively regulates TGF-β signaling and myofibroblast differentiation.
Noskovičová N; Heinzelmann K; Burgstaller G; Behr J; Eickelberg O
Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L695-L707. PubMed ID: 29351434
[TBL] [Abstract][Full Text] [Related]
3. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
[TBL] [Abstract][Full Text] [Related]
4. Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.
Wortmann A; He Y; Christensen ME; Linn M; Lumley JW; Pollock PM; Waterhouse NJ; Hooper JD
J Biol Chem; 2011 Dec; 286(49):42303-42315. PubMed ID: 21994943
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.
He Y; Wortmann A; Burke LJ; Reid JC; Adams MN; Abdul-Jabbar I; Quigley JP; Leduc R; Kirchhofer D; Hooper JD
J Biol Chem; 2010 Aug; 285(34):26162-73. PubMed ID: 20551327
[TBL] [Abstract][Full Text] [Related]
6. The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
Benes CH; Poulogiannis G; Cantley LC; Soltoff SP
Oncogene; 2012 Feb; 31(5):653-63. PubMed ID: 21725358
[TBL] [Abstract][Full Text] [Related]
7. Regulation of inside-out β1-integrin activation by CDCP1.
Pollan SG; Huang F; Sperger JM; Lang JM; Morrissey C; Cress AE; Chu CY; Bhowmick NA; You S; Freeman MR; Spassov DS; Moasser MM; Carter WG; Satapathy SR; Shah K; Knudsen BS
Oncogene; 2018 May; 37(21):2817-2836. PubMed ID: 29511352
[TBL] [Abstract][Full Text] [Related]
8. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
[TBL] [Abstract][Full Text] [Related]
9. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation.
Kollmorgen G; Bossenmaier B; Niederfellner G; Häring HU; Lammers R
PLoS One; 2012; 7(12):e53050. PubMed ID: 23300860
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.
Gandji LY; Proust R; Larue L; Gesbert F
PLoS One; 2015; 10(4):e0123472. PubMed ID: 25876044
[TBL] [Abstract][Full Text] [Related]
12. Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers.
Nelson LJ; Wright HJ; Dinh NB; Nguyen KD; Razorenova OV; Heinemann FS
Am J Pathol; 2020 Feb; 190(2):484-502. PubMed ID: 31843498
[TBL] [Abstract][Full Text] [Related]
13. CDCP1 promotes compensatory renal growth by integrating Src and Met signaling.
Kajiwara K; Yamano S; Aoki K; Okuzaki D; Matsumoto K; Okada M
Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574034
[TBL] [Abstract][Full Text] [Related]
14. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
[TBL] [Abstract][Full Text] [Related]
15. Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.
Casar B; He Y; Iconomou M; Hooper JD; Quigley JP; Deryugina EI
Oncogene; 2012 Aug; 31(35):3924-38. PubMed ID: 22179830
[TBL] [Abstract][Full Text] [Related]
16. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.
Law ME; Ferreira RB; Davis BJ; Higgins PJ; Kim JS; Castellano RK; Chen S; Luesch H; Law BK
Breast Cancer Res; 2016 Aug; 18(1):80. PubMed ID: 27495374
[TBL] [Abstract][Full Text] [Related]
17. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
[TBL] [Abstract][Full Text] [Related]
18. SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells.
Kawase N; Sugihara A; Kajiwara K; Hiroshima M; Akamatsu K; Nada S; Matsumoto K; Ueda M; Okada M
J Biol Chem; 2022 Mar; 298(3):101630. PubMed ID: 35085554
[TBL] [Abstract][Full Text] [Related]
19. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]